TRXADE GROUP INC (OTCMKTS:TRXD) on Focus After Report of Less Shorts

October 13, 2018 - By Adrian Erickson

Trxade Group, Inc. (OTCMKTS:TRXD) Logo

The stock of TRXADE GROUP INC (OTCMKTS:TRXD) registered a decrease of 50% in short interest. TRXD’s total short interest was 400 shares in October as published by FINRA. Its down 50% from 800 shares, reported previously. With 5,100 shares average volume, it will take short sellers 0 days to cover their TRXD’s short positions.

It closed at $0.42 lastly. It is down 0.00% since October 13, 2017 and is . It has underperformed by 15.62% the S&P500.

Trxade Group, Inc. owns and operates a business-to-business Web marketplace focused on the United States pharmaceutical industry. The company has market cap of $13.56 million. The firm offers Web based market platform that enables trade among healthcare buyers and sellers of pharmaceuticals, accessories, and services. It has a 42 P/E ratio. The Company’s principal services and products include and, which are Web pharmaceutical marketplaces; Pharmabayonline that provides access to proprietary pharmaceutical data analytics to the United States independent pharmacies, pharmaceutical shortage databases, proposed governmental reimbursement benchmarks comparison and analysis, and a proprietary suggested national retail drug benchmark; and RxGuru, a service desktop software application, which provides daily drug pricing and analytics to the independent pharmacists.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.